Institut für Experimentelle und Klinische Pharmakologie und Toxikologie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

HCN4 channels sense temperature and determine heart rate responses to heat (2025) Wu Y, Wang Q, Granger J, Reyes Gaido O, Lopez-Cecetaite G, Aguilar EN, Ludwig A, et al. Journal article Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs (2025) Gremke N, Besong I, Stroh A, von Wichert L, Witt M, Elmshäuser S, Wanzel M, et al. Journal article Pharmacological and resting state fMRI reveal Osteocalcin’s effects on mouse brain regions with high Gpr37 and Gpr158 expression (2025) Freus N, Wank I, Häfele M, Kalinichenko L, Müller CP, Strobelt S, Ludwig A, et al. Journal article Distinct functional cerebral hypersensitivity networks during incisional and inflammatory pain in rats (2025) Kreitz S, Pradier B, Segelcke D, Amirmohseni S, Heß A, Faber C, Pogatzki-Zahn EM Journal article Shortage of antiseizure medication in Germany: How big is the problem? (2025) Steidl J, Krebs S, Kostev K, Schwab S, Hamer H Journal article Factors Associated With Persisting Olfactory Dysfunction After COVID-19 (2025) Prem B, Liu DT, Boehme K, Maurer MT, Renner B, Mueller CA Journal article An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors (2025) Vogg N, North E, Geßner A, Fels F, Heinrich M, Kroiss M, Kurlbaum M, et al. Journal article Meis transcription factors regulate cardiac conduction system development and adult function (2025) Muñoz-Martín N, Simon-Chica A, Díaz-Díaz C, Cadenas V, Temiño S, Esteban I, Ludwig A, et al. Journal article Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation (2024) Bolik KV, Hellmann J, Maschauer S, Neu E, Einsiedel J, Riss P, Vogg N, et al. Journal article Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study (2024) Fischer S, Donhauser M, Cohnen SE, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, et al. Journal article